Answers are grounded in this paper and cite their sources.
Diabetes mellitus (DM) is a common endocrine disorder that can lead to various complications, including cardiovascular diseases, nephropathy, and neuropathy. These complications are associated with damage to the endothelial glycocalyx (EG), which is a layer of carbohydrates that covers the surface of endothelial cells and plays an important role in maintaining vascular integrity and regulating inflammation. In recent years, researchers have shown interest in targeting EG as a potential treatment for DM complications. This article will discuss existing approaches and medications that can affect EG, based on recent studies.
No takes yet. Share an insight, caveat, or question.
Vorobyova et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: